Alabama Reminder to follow both state and federal law: Medicaid Rule No. 560-X-16-.20(5)

Alabama Medicaid Rule No. 560-X-16-

.20(5) Quantity Limitations

(5) Maintenance medications are those generally used to

treat chronic conditions or illnesses and are ordered/pre

-

scribed and taken regularly and continuously. Medicaid

recipients can obtain a three month supply of maintenance

medications as designated by the Agency. The patient

must first have demonstrated stability for at least 60

days (same strength and dose) on a given maintenance

medication. Only one co-pay is collected and only one

dispensing fee is paid for the three month supply. A list

of maintenance medications is available on the Medicaid

website.

Medicaid has disseminated and posted guidance to the

Alabama Medicaid Agency website, which is very clear in that

pharmacists should always follow both state and federal phar

-

macy law. The Alabama Medicaid Agency guidance is avail

-

able on its website at

www.medicaid.alabama.gov/documents/

4.0_ Programs/4.5_ Pharmacy_ Services/4.5.4_ Drug _ Info/

4.5.4_Maintenance_Supply_Guidance_Revised_9-5-13.pdf

and states the following: “Alabama State Board of Pharmacy 

 

law prohibits the quantity of a prescription to be changed

without prescriber approval. Approval from the prescriber

must be attained prior to dispensing a maintenance supply."

quoted from here

Kentucky racing commission panel to look at whether medication rule places blame in proper place

Kentucky racing commission panel to look at whether medication rule places blame in proper place

Monday, January 27, 2014

Proposed changes to standardbred medication rules and penalties by the Kentucky Horse Racing Commission have prompted a bit of a tempest in thoroughbred circles. The issue will be on the agenda Tuesday for a special meeting of the commission’s rules committee.

read more

HHS OIG Work Plan for FY 2014 - Office of Inspector General

PDF]

HHS OIG Work Plan for FY 2014 - Office of Inspector General - U.S. ...

oig.hhs.gov/.../Work-Plan-2014.pdf‎

• Cached
• Share
  View shared post

United States Department...

Loading...

18 hours ago - management processes, including key issues such as food and drug safety, child support ...... Payment for compounded drugs under Medicare Part B (new) .

Military Officals Briefing on Tricare and Compounding Prescription Coverage

Compounded Prescriptions
TRICARE does not cover drugs that are not approved by the FDA and cannot reimburse for non-FDA approved bulk chemical ingredients in compound prescriptions.
A planned review of this policy has been suspended due to the recently enacted "Drug Quality and Security Act."
TRICARE will re-examine its policy after an FDA review, but no date has been set for completion.
- See more at: http://www.moaa.org/
Main_Menu/Take_Action/Top_Issues/Enjoying_Retirement/
Health_Care/TRICARE_Officials_Brief_MOAA.html#sthash.NRpeybze.dpuf

PCCA Job Opening for Inside Sales Manager

Inside Sales Manager

PCCA

Houston, Texas Area - Jan 14, 2014

Job Detail:

PCCA (Professional Compounding Centers of America), an independent compounding pharmacy's complete resource for fine chemicals, devices, equipment, training & support, is looking for an Inside Sales Manager join their inside sales team in Houston, TX. Relocation assistance is available for the r...

more here

The Drug Shortage Report: Trial Delayed for South Lyon Pharmacy & Pharmacist...

The Drug Shortage Report: Trial Delayed for South Lyon Pharmacy & Pharmacist...:  A trial to determine whether or not to uphold the license suspension of a South Lyon pharmacy has been delayed. A trial had been set for th...

Third Question of the Day February 1, 2014 Is it fair of the federal government (Congress and FDA) to force compounding pharmacists and pharmacies to make decisions about whether to stay traditional compouders or convert to outsourcers when all the guidance and drug lists have no been put in place?

While the argument is that no one has to decide anything right now as far as the DQSA, in reality that is not true--compounding pharmacists who own compounding pharmacies are having to make tough decisions right now about which direction to go.  It is not a matter of just snapping their fingers and filling out paper work. For those good, honest compounders, many factors have to be weighed and balanced.  The factors relate to facilities, drugs to compound, and staff to employee or in some cases lay off, funding and resources, etc.  These are very difficult decisions requiring a lot of careful weighing of these factors.  Guidance needs to be given to those compounders who do both human and animals since a distinction was made by Congress.  They face what appears to be much tougher decisions than those who do solely human compounds or solely veterinary compounds (who aren't affected by DQSA).  The more information the FDA and the states can provide and the sooner they can provide it the better for the good and much needed compounding pharmacists and pharmacies. 

Second Question of the Day February 1, 2014 What will it take to convince groups that represents compounding pharmacies and pharmacists to police their own bad actors so that the entire class of good compounders are not also punished along with the bad compounders?

Question of the Day February 1, 2014 What will it take to get states to enforce their own rules and regulations against compounding pharmacie and pharmacists?

Great Cheat Sheet from IACP on When FDA Comments and Nominations are Due from Compounders

IACP Reference Documents: FDA Comments and Nominations Due Dates - What is Due When?

IACP has created some documents to help you navigate the myriad of FDA Comments and Nominations due dates for the coming months.

Click here for a Due Dates Reference Sheet.
Click here for a comprehensive IACP "Cheat Sheet" outlining exactly what is due and when, as well as FDA links providing instructions on how to submit your information.

For more information, please contact IACP at iacpinfo@iacprx.org.